TP53 and neoplasm: In response to the variability in immune cell abundance in different tumor cells, it is crucial to explore immunotherapy for WT p53 reactivation in combination with other effective immunotherapeutic approaches to enhance immune cell recruitment and maintain the normal function of antitumor immune cells.